BY SUNILA DIXIT AND SHAMBHAVI NAIK
The Union and various state governments have conducted seroprevalence surveys at national and city/state levels to study the spread of COVID-19. We argue
The disparity in estimated cases as per seroprevalence studies and actual detected cases is a result of limited testing capacity and flawed testing strategy.
City level sero-surveys can help understand testing demand and should be used to tailor testing capacity at the local level.
No comments:
Post a Comment